DILI imaging of hepatocytes

DILI imaging of hepatocytes cultured on Cell-able® with CellVoyager CQ1

CellVoyager CQ1 and Cell-able® plates are applicable to drug-induced liver injury (DILI) study utilizing high content screening assay as shown in the following.

DILI imaging of hepatocytes

Experimental:

Human primary hepatocytes were co-cultured on Cell-able® with 3T3-Swiss albino mouse fibroblast cells. The 3D spheroids were stained with monochlorobimane (mBCl) for reduced glutathione (GSH/ blue), Bodipy 493/503 for lipid droplets (Oil/green), Tetramethylrhodamine methyl ester (TMRM) for mitochondrial membrane potential (MMP/ red) and HCS Nuclera Mask Deep Red for nuclei (purple) after 3-days exposure with Aspirin (negative compound) and Troglitazone (positive compound). The images were acquired with with CellVoyager CQ1.

Cell-able is a registered trademark of Toyo Gosei Co., Ltd. in US and Japan.

Link to Toyo Gosei Co., Ltd. :


Our Social Medias

We post our information to the following SNSs. Please follow us.

  Follow us Share our application
•Twitter @Yokogawa_LS Share on Twitter
•Facebook Yokogawa Life Science Share on Facebook
•LinkedIn Yokogawa Life Science Share on LinkedIn

 

Yokogawa's Official Social Media Account List

Social Media Account List


Les produits et solutions liés

  • CellPathfinder

    CellPathfinder is designed for our HCA systems, CQ1 and the CellVoyager series. From beginners to experts, the analysis software lets you quantify subtle physiological changes and even label-free samples with various graph options.

    Voir plus
  • CV8000 High-Throughput System

    CellVoyager CV8000 is the most advanced high-content screening system. The improved built-in incubator lets you analyze extended live cell responses. With its expandability, 4 cameras, 5 lasers and an optional built-in pipettor, the system permits increasingly complex assay development and high-content screening.

    Voir plus

Haut